Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.47 |
| ▸ | CTSL | P07711 | 3/20 | 0.45 |
| ▸ | CTSS | P25774 | 3/20 | 0.45 |
| ▸ | CTSK | P43235 | 3/20 | 0.45 |
| ▸ | CTSH | P09668 | 1/20 | 0.45 |
| ▸ | CALCR | P30988 | 6/20 | 0.45 |
| ▸ | RAMP3 | O60896 | 2/20 | 0.44 |
| ▸ | NMBR | P28336 | 2/20 | 0.43 |
| ▸ | GRPR | P30550 | 2/20 | 0.43 |
| ▸ | REN | P00797 | 1/20 | 0.43 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.42 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.42 |
| ▸ | TFPI | P10646 | 1/20 | 0.42 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30657490 | 0.91 | CALCRL (0.43) | F2CALCRRAMP3RENTFPI | |
| SCHEMBL29726608 | 0.90 | CALCRL (0.44) | F2CALCRRAMP3RENTFPI | |
| SCHEMBL30657491 | 0.86 | F2 (0.42) | F2CALCRRAMP3CALCRL | |
| SCHEMBL30657497 | 0.85 | CALCRL (0.44) | RENCALCRL | |
| SCHEMBL30657496 | 0.84 | CALCRL (0.45) | F2CALCRRAMP3CALCRL | |
| SCHEMBL30657494 | 0.84 | CALCRL (0.51) | RENCALCRL | |
| SCHEMBL31140791 | 0.83 | CALCRL (0.46) | F2CALCRRAMP3RENTFPI | |
| SCHEMBL29726644 | 0.83 | CALCRL (0.46) | F2CALCRRAMP3RENTFPI | |
| SCHEMBL31318919 | 0.80 | CALCRL (0.46) | F2CALCRRENCALCRL | |
| SCHEMBL3253193 | 0.79 | PTPN1 (0.43) | F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12133720-B2 | Methods and compositions for restoring homeostatic capacity of a subject | Palo Alto Investors LP (US) | 2024-11-05 | — | — | US | disclosed |
| EP-4397770-A1 | STABILISATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | PreAnalytiX GmbH (CH) | 2024-07-10 | — | — | EP | disclosed |
| EP-3401406-B1 | STABILISATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | PREANALYTIX GMBH (CH) | 2023-11-29 | — | — | EP | disclosed |